Menu
Our research activities have a clear objective: to conduct and facilitate excellent clinical cancer research at the international level in order to improve the treatment and quality of life of cancer patients. As we are not a pharmaceutical company, our real “product” is the gain of scientific knowledge, which we achieve through clinical trials with our partners that focus on patient-relevant endpoints such as survival and quality of life.
Sponsored by our institution and conducted on an international scale, our investigator-initiated trials result from collaborative efforts between our internal experts and external partners, including esteemed physicians and oncologists from various university hospitals.
We recognize the vital role of translational research in our study designs. We are dedicated to advancing our understanding of cancer pathogenesis and development, and to achieve this, we integrate translational elements into our research.
We aim at improving personalized cancer therapy with our academic partners by establishing large networks and registries for molecular profiling. Our interactive PLATON Network (Platform for Analyzing Targetable Mutations) brings together comprehensive molecular profiling, extensive clinical data of cancer patients, QoL, education, and clinical trial information to advance cancer research and treatment.
In addition to clinical trials, we conduct real-world studies in diverse healthcare settings. These studies provide valuable insights into the practical application of treatments, their effectiveness in routine care, and patient outcomes in real-world scenarios. By conducting research in real-life settings, we aim to bridge the gap between controlled clinical environments and the complexities of everyday clinical practice.
